Cargando…

Correction: M(2)HepPrEP: study protocol for a multi-site multi-setting randomized controlled trial of integrated HIV prevention and HCV care for PWID

Detalles Bibliográficos
Autores principales:	Martel-Laferrière, Valérie, Feaster, Daniel J., Metsch, Lisa R., Schackman, Bruce R., Loignon, Christine, Nosyk, Bohdan, Tookes, Hansel, Behrends, Czarina N., Arruda, Nelson, Adigun, Oluleye, Goyer, Marie-Eve, Kolber, Michael A., Mary, Jean-Francois, Rodriguez, Allan E., Yanez, Iveth G., Pan, Yue, Khemiri, Rania, Gooden, Lauren, Sako, Aïssata, Bruneau, Julie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513950/ https://www.ncbi.nlm.nih.gov/pubmed/36167548 http://dx.doi.org/10.1186/s13063-022-06724-9

Ejemplares similares

M(2)HepPrEP: study protocol for a multi-site multi-setting randomized controlled trial of integrated HIV prevention and HCV care for PWID
por: Martel-Laferrière, Valérie, et al.
Publicado: (2022)

Why Maximizing Quality-Adjusted Life Years, rather than Reducing HIV Incidence, Must Remain Our Objective in Addressing the HIV/AIDS Epidemic
por: Nosyk, Bohdan, et al.
Publicado: (2019)

Impact of routine opt-out HIV/HCV screening on testing uptake at a syringe services program: An interrupted time series analysis
por: Bartholomew, Tyler S., et al.
Publicado: (2020)

Estimating the epidemiological impact of reaching the objectives of the Florida integrated HIV prevention and care plan in Miami-Dade County
por: Zang, Xiao, et al.
Publicado: (2023)

Developing a dynamic HIV transmission model for 6 U.S. cities: An evidence synthesis
por: Krebs, Emanuel, et al.
Publicado: (2019)

Project T-SHARP: study protocol for a multi-site randomized controlled trial of tele-harm reduction for people with HIV who inject drugs
por: Tookes, Hansel E., et al.
Publicado: (2023)

A Harm Reduction Approach to Treating Opioid Use Disorder in an Independent Primary Care Practice: a Qualitative Study
por: Kapadia, Shashi N., et al.
Publicado: (2021)

The effects of COVID-19 on New York State’s Drug User Health Hubs and syringe service programs: a qualitative study
por: Ude, Mercy, et al.
Publicado: (2023)

Enhancing patient navigation to improve intervention session attendance and viral load suppression of persons with HIV and substance use: a secondary post hoc analysis of the Project HOPE study
por: Stitzer, Maxine, et al.
Publicado: (2017)

225. Dalbavancin Usage in Patients Who Inject Drugs (PWID)
por: Patel, Kaya, et al.
Publicado: (2023)

A qualitative study exploring the impact of the COVID-19 pandemic on People Who Inject Drugs (PWID) and drug service provision in the UK: PWID and service provider perspectives
por: May, Tom, et al.
Publicado: (2022)

Cost-Effectiveness Analysis in Implementation Science: a Research Agenda and Call for Wider Application
por: Krebs, Emanuel, et al.
Publicado: (2021)

Syringe services program (SSP) operational changes during the COVID-19 global outbreak
por: Bartholomew, Tyler S., et al.
Publicado: (2020)

Impact of an Accelerated Pretreatment Evaluation on Linkage-to-Care for Hepatitis C-infected Persons Who Inject Drugs
por: Martel-Laferrière, Valérie, et al.
Publicado: (2022)

On-site bundled rapid HIV/HCV testing in substance use disorder treatment programs: study protocol for a hybrid design randomized controlled trial
por: Frimpong, Jemima A., et al.
Publicado: (2016)

Viral load testing to monitor the HIV epidemic among PWID in Vietnam
por: Khuu, Nghia V., et al.
Publicado: (2018)

1071. Social Determinants of health (SDOH) among PWID living with HCV
por: Corro, Luis Gonzalez, et al.
Publicado: (2020)

Quality of life in patients with visual impairment in Ibadan: a clinical study in primary care
por: Adigun, Kehinde, et al.
Publicado: (2014)

The Evolving Landscape of the Economics of HIV Treatment and Prevention
por: Nosyk, Bohdan, et al.
Publicado: (2012)

587. HIV Care Outcomes Among PWID in San Francisco, 2009–2015
por: Kim, Nathan, et al.
Publicado: (2018)

1021. Repeat Infective Endocarditis (rIE) in Persons Who Inject Drugs (PWID)
por: Huang, Glen, et al.
Publicado: (2018)

2255. The Use of Dalbavancin for Staphylococcus aureus Bacteremia in Persons Who Inject Drugs (PWID)
por: Van Hise, Nicholas W, et al.
Publicado: (2019)

695. Infective endocarditis in people who inject drugs (PWID) at UK Medical Center
por: Cari, Evelyn Villacorta, et al.
Publicado: (2020)

Contact Tracing for COVID-19: An Opportunity to Reduce Health Disparities and End the Human Immunodeficiency Virus/AIDS Epidemic in the United States
por: Nosyk, Bohdan, et al.
Publicado: (2020)

Application of machine learning algorithms for localized syringe services program policy implementation – Florida, 2017
por: Bartholomew, Tyler S., et al.
Publicado: (2022)

Effects of Multi-Level Eco-Labels on the Product Evaluation of Meat and Meat Alternatives—A Discrete Choice Experiment
por: Kolber, Anna, et al.
Publicado: (2023)

Needle acquisition patterns, network risk and social capital among rural PWID in Puerto Rico
por: Duncan, Ian, et al.
Publicado: (2017)

People who inject drugs (PWID) and HIV/aids cases in Mexico City: 1987–2015
por: Romero Mendoza, Martha, et al.
Publicado: (2019)

Clinical audit of cardio-metabolic monitoring in people with intellectual disability (PWID) taking antipsychotic medication
por: Kyaw, Sandar, et al.
Publicado: (2021)

Integrated Infectious Disease and Substance Use Disorder Care for the Treatment of Injection Drug Use–Associated Infections: A Prospective Cohort Study With Historical Control
por: Serota, David P, et al.
Publicado: (2022)

Burden of Liver Disease among Community-Based People Who Inject Drugs (PWID) in Chennai, India
por: Solomon, Sunil S., et al.
Publicado: (2016)

Assessing Syringe Exchange Program Access among Persons Who Inject Drugs (PWID) in the District of Columbia
por: Allen, Sean T., et al.
Publicado: (2016)

Operationalizing the HIV prevention cascade for PWID using the integrated bio‐behavioural survey data from Ukraine
por: Dumchev, Kostyantyn, et al.
Publicado: (2020)

Harmonizing healthcare and other resource measures for evaluating economic costs in substance use disorder research
por: Papp, Michelle A., et al.
Publicado: (2021)

Implementation and first-year operating costs of an academic medical center-based syringe services program
por: Bartholomew, Tyler S., et al.
Publicado: (2021)

Harm reduction and health services provided by syringe services programs in 2019 and subsequent impact of COVID-19 on services in 2020()
por: Behrends, Czarina N., et al.
Publicado: (2022)

The structural and health policy environment for delivering integrated HIV and substance use disorder treatments in Puerto Rico
por: Leff, Jared A., et al.
Publicado: (2017)

Health Care Provider Stigma Toward Patients With Substance Use Disorders: Protocol for a Nationally Representative Survey
por: Parish, Carrigan Leigh, et al.
Publicado: (2023)

Features extraction from multi-spectral remote sensing images based on multi-threshold binarization
por: Rusyn, Bohdan, et al.
Publicado: (2023)

Patients Followed in an Addiction Medicine Clinic Are Less Likely to Be Eligible to Hepatitis C Drug Studies Regardless of Drug Use
por: Doré, Gabrielle, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8prnsja83r5g0bk0af52d1ncmm